MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12026-014-8615-z

Медицинская библиотека · Immunologic research · 2015

Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future.

Cantarini Luca, Rigante Donato, Vitale Antonio, Napodano Salvatore, Sakkas Lazaros I, Bogdanos Dimitrios P, Shoenfeld Yehuda

СтатьяОбзорПеревод в очереди

Аннотация

The etiology and pathogenesis of systemic sclerosis are still largely unknown, but a variety of humoral and cellular autoimmune phenomena have been documented. In addition, the rarity of the disease, the broad spectrum of clinical manifestations, and the relevant risk of severe complications as well as the highly variable disease course render its management a major challenge. Some immunomodulatory agents have been used, but no single agent has given a convincing proof of effectiveness, and treatment has remained largely symptomatic through recent years. Novel therapies are currently being tested and may have the potential of modifying the disease process and overall clinical outcome. Efficacy of intravenous immunoglobulins (IVIG) in different regimens (1-2 g/kg of body weight, administered over 2-5 consecutive days) has been described in a limited number of trials and small case series, showing benefits in skin, articular, and lung interstitial disease symptoms. However, studies on IVIG in systemic sclerosis still remain few, and further randomized controlled trials should be undertaken to assess their clinical effectiveness or define the optimal dosage and times of administration.

Для цитирования: Cantarini Luca, Rigante Donato, Vitale Antonio, Napodano Salvatore, Sakkas Lazaros I, Bogdanos Dimitrios P, Shoenfeld Yehuda. Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future.. Immunologic research. 2015. DOI: 10.1007/s12026-014-8615-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.